The European Glaucoma Society, Belgium

Similar documents
National Center for Tumor Diseases (NCT) Heidelberg, Germany

Central Manchester University Hospitals NHS Foundation Trust, UK

The Centre for Disease Prevention and Control, Latvia

European Society of Cardiology, France

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

Ministry for Health, the Elderly and Community Care, Malta

Hospital Carlos Haya. Malaga, Spain

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

Cystic Fibrosis Europe (CFE), Germany

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

INSTITUTE OF CHILD HEALTH, Greece

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

Department of Medical Genetics, Medical School, University of Athens, Greece

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

VSOP, Lupus Netherlands

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

European Haemophilia Consortium

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

ERN board of Member States

European Reference Networks (ERN) Guide for patient advocates

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

Document: Report on the work of the High Level Group in 2006

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

Call for Nominations. CARLOS V European Award

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

Delegations will find below the above-mentioned Council conclusions, as endorsed by the Council (General Affairs) on 14 September 2015.

Brokerage for the first ProSafe Call Dina Carrilho Call Secretariat Foundation for Science and Technology (FCT), Portugal

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »

An integrated patient care approach Improvement of hospital-based IBD care: 2014 report from KPMG

116 Help Lines for Rare Diseases

Info Session Webinar Joint Qualifications in Vocational Education and Training Call for proposals EACEA 27/ /10/2017

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

FP7: Marie Curie Actions

JOINT DECLARATION ON THE PROMOTION AND THE ENFORCEMENT OF CANCER PATIENTS RIGHTS

JOB VACANCY AT EIT FOOD

Presentation of Interreg Europe

ERC Grant Schemes. Horizon 2020 European Union funding for Research & Innovation

ERN Assessment Manual for Applicants

EUREKA and Eurostars: Instruments for international R&D cooperation

A European workforce for call centre services. Construction industry recruits abroad

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

Implementing the 3rd Health Programme. Ingrid Keller Coordinator Health Programme Consumer, Health and Food Executive Agency

SOUTH AFRICA EUREKA INFORMATION SESSION 13 JUNE 2013 How to Get involved in EUROSTARS

Assessment of Erasmus+ Sports

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

ECHA Helpdesk Support to National Helpdesks

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

The EUREKA Initiative An Opportunity for Industrial Technology Cooperation between Europe and Japan

Terms of reference 6 th call for proposals

Jean Monnet support to associations

JOB VACANCY AT EIT FOOD

EUROPEAN COMMISSION HEALTH AND CONSUMER PROTECTION DG. Directorate C: Public Health and Risk Assessment Unit C2 - Health information

ASTP-Proton is the premier, pan-european association for professionals involved in knowledge transfer between universities and industry.

European Investment Advisory Hub

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

Highlights. Make. the. right. FACEBOOK.COM/ DHCPLUS. euroheat.org stratego-project.

European Funding Opportunities in the field of Language Teaching and Learning

Spreading knowledge about Erasmus Mundus Programme and Erasmus Mundus National Structures activities among NARIC centers. Summary

The ERC funding strategy

Table Of Content. Strengthening voluntary cooperation between Member States to improve the health of EU citizens... 2 Summary... 3 Work Package...

Horizon 2020 LEIT-Space

The Third EU Health Programme

Erasmus+ Programme Jean Monnet Activities. Snejina Nikolova Education, Audiovisual and Culture Executive Agency (EACEA)

STUDENT AGREEMENT For the ERASMUS MUNDUS Joint Master Degree (EMJMD) in Sustainable Tropical Forestry (SUTROFOR)

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

International dimension of Higher Education 27/06/2015

Do terms like FP6, CORDIS, Specific Programme, Call for

S. Tziaferi. President FOHNEU Assistant Professor in Community Nursing Dep. of Nursing University of Peloponnese

2017 Erasmus+ KA1 VET and Adult Education Handbook

JOB VACANCY AT EIT FOOD

Regulatory Cooperation in Europe. Natalie McCoy, CEER Secretary General INOGATE Conference - Brussels, 1 February 2013

Involvement of ESF and EMRC in Clinical Trials Wellcome Trust, London, 16 March 2010 by Dr. Maria Manuela Nogueira ESF Science Officer.

Programme Officer International Development

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

European network of paediatric research (EnprEMA)

Call for proposals EAC / S01 / Pilot project for the development of Sector Skills Alliances. Frequently asked questions (updated on 22/06/2012)

1. Introduction, purpose of this Standard Operating Procedure (SOP)

is a growing initiative of funding institutions fostering collaborative research and innovation with African and European researchers and innovators.

INTERREG ATLANTIC AREA PROGRAMME CITIZENS SUMMARY

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary

EEA and Norway Grants digital annual report 2018

1. Introduction, purpose of this Standard Operating Procedure (SOP)

The Pharmaceutical Risk Assessment Committee (PRAC) of the EMA

JOB VACANCY AT EIT FOOD

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

European Investment Advisory Hub

EFLM EUROPEAN FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Developing a European Registry for Rare Anaemias

Caring for people with multimorbidity in Europe: an overview from the ICARE4EU project

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

ERA-Can+ twinning programme Call text

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

The European Institute of Innovation and Technology (EIT) A Body of the European Commission Status, past and future

Transcription:

The European Glaucoma Society, Belgium 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Health professionals' organisations (e.g. doctors, nurses, managers) Please indicate level: European Union umbrella organisation Please indicate Member States representation: Pan European Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: The European Glaucoma Society 1.3 Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: 1. Please indicate the number of EU Member States and EEA countries (Norway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1.5 If need be, can we contact you by e-mail to obtain further information on your submission? 1.5.1 Please provide an e-mail address where we can contact you: thierry.zeyen@uzleuven.be BE 23 Yes 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): prof. dr. em. Thierry Zeyen Tel. secretariat +32 16 332372 - Tel. mobile +32 76 212638

1.7 Please provide additional contact details if needed: UZ Leuven campus Sint-Rafaël Kapucijnenvoer 33 B - 3000 Leuven Belgium 2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of CoE and HSHC? 2.1.1 Space for further comments: active involvement in glaucoma healthcare including training in clinical skills 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) High Highly specialised healthcare provision Costs and economic evaluation Priorities, description and characteristics of CoE and HSHC Ethical analysis Social aspects Professional performance, clinical practice, quality and safety of specialized healthcare Assessment/evaluation/certification of clinical practice and healthcare providers Information system, coding Engineering/e-health 2.2.1. Space for further comments: 2.3 Is highly specialised healthcare a priority in your organisation's strategies and work plans? Very high 2.3.1 Space for further comments: Compilation, updating and disseminating "The Definitions and Guidelines for Glaucoma" at national and European level; annual training activities for clinical skills

2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Medical/Surgical speciality Please specify: 2.5. Has your organisation/centre been directly involved in the Frequently design or assessment of professional standards and criteria related with highly specialised healthcare? glaucoma diagnosis, treatment and management 2.5.1 Please describe your role in such actions/projects: Involved in the compilation and updating of the disease-specific guidelines and in the organising of continuous education and training of members 2.6. Has your organisation been involved in projects/activities Non applicable supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? 2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? Yes 2.7.1 Space for further comments: European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd Edition. Savona, Italy: DOGMA..Srl; 2008 ; http://www.eugs.org/eng/egs_guidelines.asp - updated version 201 2.13. What is the scope of the network? 2.1. Which kind of network? 2.1.1 Space for further comments:

2.15. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, 5 = very interested) 2.15.1 Space for further comments: 3. Proposed criteria for ERN (scope, general and specific criteria) 3.1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN 3.1.1. Need of highly specialised healthcare 3.1.1.1. Complexity of the diagnosis and treatment 3.1.1.2. High cost of treatment and resources 3 3.1.1.3. Need of advanced/highly specialised medical equipment or infrastructures 3.1.2. Need of particular concentration of expertise and resources 3.1.2.1. Rare expertise/need of concentration of cases 2 3.1.2.2. Low prevalence/incidence/number of cases 2 3.1.2.3. Evaluated experiences of Member States 3.1.3. Based on high-quality, accessible and cost-effective healthcare 3.1.3.1. Evidence of the safety and favourable risk-benefit analysis 5

3.1.3.2. Feasibility and evidence of the value and potential positive outcome (clinical) 3.1.. Do you recommend any additional criteria or option that would effectively address the issue? No 3.1.5. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? 3.1.5.1 Explain your proposal in free text: Glaucomas due to lack of effective system-wide infrastructure, particularly in the links to primary care rare glaucoma conditions such as congenital glaucoma Yes 3.2. General criteria of the centres wishing to join a European Reference Network 3.2.1. Organisation and management 3.2.2. Patients empowerment and centered care 5 3.2.3. Patient care, clinical tools and health technology assessment 3.2.. Quality, patient safety and evaluation framework policies 5 3.2.5. Business continuity, contingency planning and response capacity 3.2.6. Information systems, technology and e-health tools and applications 3.2.7. Overall framework and capacity for research and training 3 3

3.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 3.2.9. Do you recommend any additional option that would effectively address the issue? 3.2.9.1. Space for further comments: No 3.3. Specific criteria regarding the areas of expertise 3.3.1. Competence, experience and good outcomes and care 3.3.2. Specific resources and organisation: 3.3.2.1. Human resources 3.3.2.2. Team/centre organisation 3.3.2.3. Structural conditions 3.3.2.. Specific equipment 3.3.2.5. Presence and coordination with other required complementary units or services 3.3.3. Patient care pathways, protocols and clinical guidelines in the field of expertise 3.3.. External coordination, care management and follow-up of patients 3.3.5. Research, training, health technology assessment in the field of expertise 3.3.6. Specific information systems 3 5

3.3.7. Do you recommend any additional criteria or option that would effectively address the issue? 3.3.7.1. Space for further comments: No further comments No